News releases

HungaroTrial has been selected as the full service provider for a PhaseII. multicenter, multinational clinical trial

Published on 08 September 2014

HungaroTrial has been selected as the full service provider for a Phase II. multicenter, multinational clinical trial in chronic lymphocytic leukemia indication. The medical team of our company has been involved also into the protocol finalization process and preliminary regulatory consultations. HungaroTrial will integrate and harmonize the cooperation of all involved parties of this complex oncology project.


Copyright: HungaroTrial 2018